REMS Stakeholder Survey - 2023

The REMS Industry Consortium, Inc. (RIC) is a nonprofit organization that brings together the perspectives of organizations that sell, or anticipate selling, prescription drugs or biologics subject to Risk Evaluation and Mitigation Strategies (REMS).  The RIC’s mission is to foster collaboration and innovation to advance patient safety, appropriate access, and best practices in REMS-related drug and biologic risk management.

To better understand and attempt to quantify some of the challenges faced by stakeholders involved in the prescribing or dispensing of REMS Products, the RIC Vendor, Innovation, and Technology work group has developed a brief survey. 

We plan to share the results of this survey with the RIC membership and potentially with the FDA.

Please avoid mention of any specific products or adverse events.  Published survey results will redact any information that may unintentionally identify a specific REMS Program or Adverse Event.

CLICK HERE TO BEGIN THE SURVEY.

Thank you for your support of this important initiative.